[A-List] Clean Safe Energy (NOT!) - NRC to distribute 9 million potassium iodide tablets around U.S. nuclear plants
Leighm
the.buffalo.in.the.midst at gmail.com
Thu Apr 2 17:50:22 MDT 2009
Because I get too many newsletters... Government Security News.com:
NRC to distribute 9 million potassium iodide tablets around U.S. nuclear
plants
By Jacob Goodwin, Editor-in-Chief
Published March 30th, 2009
The Nuclear Regulatory Commission is planning to distribute
approximately nine million potassium iodide tablets to state and local
governments and Native-American tribes. The tablets will be stockpiled
for populations living within a “10-mile emergency planning zone”
surrounding commercial nuclear power plants across the country.
Revised rules issued by the NRC in 2001 require that state, local and
tribal governments “consider including potassium iodide (KI) as a
protective measure for the general public to supplement sheltering and
evacuation in the unlikely event of a severe nuclear power plant
accident,” according to a solicitation released by the NRC earlier this
month.
“Potassium iodide is a salt, similar to table salt,” explains the NRC’s
Web site. “It is routinely added to table salt to make it ‘iodized.’
Potassium iodide, if taken within the appropriate time and at the
appropriate dosage, blocks the thyroid gland's uptake of radioactive
iodine and thus reduces the risk of thyroid cancers and other diseases
that might otherwise be caused by thyroid uptake of radioactive iodine
that could be dispersed in a severe reactor accident.”
When the NRC originally considered this policy, it had planned to
distribute adult-sized tablets with a dosage of 130 mg, but since the
Food and Drug Administration has approved a pediatric dose of 65 mg, the
NRC has decided to distribute that smaller tablet. “Each tablet shall be
scored-in to enable the user to break the tablet into at least two
pieces,” says the solicitation, and each tablet will be individually
wrapped in blister packaging.
The NRC solicitation listed more than 30 possible locations across the
country that might receive distributions of the KI tablets. Delivery
will be required within three months of contract award, and the tablets
must have a shelf life of at least five years and nine months
thereafter, says the solicitation.
Additional information is available from Sheila Bumpass, of the NRC’s
contracts division, at 301-492-3484.
http://www.gsnmagazine.com/cms/features/news-analysis/1757.html
More information about the A-List
mailing list